Objectives: To determine the incidence of in utero meconium passage and the rate of associated complications among VLBW infants.
Introduction
The passage of meconium in utero is a frequent occurrence among full-term infants. The incidence rises with advancing gestational age, ranging from 13% for infants 36-39 weeks to 31.5% for infants born after 42 weeks gestation. 1, 2 Preterm infants have been reported to pass meconium in utero as well. However, the reported incidence of meconium-stained amniotic fluid is only 3-6.7% in the preterm population. 1, [3] [4] [5] [6] In full-term infants, it is well established that the in utero passage of meconium indicates an increased risk for adverse outcomes. Such infants have an increased likelihood of perinatal 3, 7 and neonatal mortality, 3, [8] [9] [10] severe acidemia, 7, 9 need for cesarean section delivery, 7, 9 need for neonatal intensive care and/or oxygen support, [10] [11] [12] and adverse neurologic sequelae. 7, 9 Similar adverse outcomes have been reported in premature infants with meconium-stained amniotic fluid. These infants have higher rates of intrapartum and postpartum death, 3 cystic periventricular leukomalacia, 13 and cerebral palsy 14, 15 than do premature infants without meconium-stained fluid.
We have found microscopic evidence of meconium staining in the placentas of women who delivered preterm but were not reported to have had either meconium-stained amniotic fluid or green placentas upon gross examination. This raised the possibility that premature infants pass meconium in utero more often than reported previously. Therefore, we designed a method to detect meconium in the placentas more accurately and used this method to determine both the true incidence of in utero meconium passage and the rate of associated perinatal complications among a large cohort of very low birth weight preterm infants.
Methods

Study design
This study was approved by the Institutional Review Board at Magee-Womens Hospital (Pittsburgh, PA) and includes both a retrospective review of medical records and a prospective evaluation of placental samples. The medical record review was conducted of infants admitted to the neonatal intensive care unit at MageeWomens Hospital from July 1997 to February 1999. Infants were included in the study if they met the following criteria: admitted to the NICU within 12 h of birth, birth weight <1350 g, survived >24 h, and if placental pathology and cranial ultrasound reports were both available. Infants were excluded if they had congenital anomalies of the brain, heart, or kidneys, twin-to-twin transfusion sequence, hydrops fetalis, or known in utero intraventricular hemorrhage.
Placental pathology
All placentas underwent routine pathologic examination by one of three pathologists, and then were reviewed prospectively by the first author who is a neonatologist, who was trained by a perinatal pathologist in the identification of meconium. Data extracted from the pathology reports included the presence or absence of brown pigment suggestive of meconium; the presence or absence of abruption or infarction; and histologic evidence of chorioamnionitis, funisitis, and/or fetal stem vessel vasculitis.
Cases in this study group reported to have histologic evidence of meconium, were re-examined as follows: Microscope slides of rolled fetal membranes including the amnion, chorion, and decidua were made and stained with hemotoxylin and eosin (H&E) as well as with Prussian blue. The slides were marked every 3 mm along the long axis of the slide and examined at these marks moving perpendicular to the long axis. A final magnification of 400 Â was used. A maximum of 10 fields/slide were studied. The slides were examined for the presence of macrophages containing pale brown pigment (See Figure 1 ). Only cells with a nucleus were counted. The macrophages are the large white blood cells, with a single nucleus, containing lysosomes that appear as either diffusely filled or with a granular appearing pale brown pigment. Meconium was then differentiated from hemosiderin by the absence of Prussian blue staining. This definition reflects the absence in the literature of a reliable stain that is positive for meconium. Meconium identified by this technique was classified as present or absent. Iron in the decidua and amnion was classified as present (( þ ) staining with Prussian blue) or absent.
Demographic information
Demographic variables, perinatal risk factors, resuscitation performed at birth and data regarding the clinical care course were collected from the infant's medical record. Main adverse events were defined as the need for endotracheal intubation or cardiopulmonary resuscitation (chest compressions and/or epinephrine) at delivery, grade III-IV intraventricular hemorrhage, cystic periventricular leukomalacia, bronchopulmonary dysplasia (oxygen requirement at 28 days of life), necrotizing enterocolitis (Bell stage II-IV), and death. Maternal charts were reviewed for the administration of antenatal steroids and risk factors for preterm delivery including preeclampsia, HELLP syndrome, clinical chorioamnionitis, premature/prolonged rupture of membranes, and clinical abruption.
Cranial ultrasounds
Cranial ultrasounds were performed on day of life number 14 and were interpreted by a pediatric radiologist. Intraventricular hemorrhages were graded as by Papile. 16 Cystic periventricular leukomalacia was defined as the presence of echolucencies >1 mm in the periventricular white matter. If more than one cranial ultrasound was available, then the most severe abnormalities were recorded.
Statistical analysis w 2 analysis was used to determine if the frequencies of adverse events and pregnancy complications differed between infants who did and did not have in utero passage of meconium. Binary logistic regression was used to determine the relative contributions of confounding factors on the incidence of need for intubation or cardiopulmonary resuscitation, and grade III-IV IVH. Demographic variables were analyzed using the Student's t-test or Kruskal-Wallis, as appropriate. Statistical analysis was performed using Minitab for windows, Release 12.23 (Minitab, State College, PA), and STATA 6.0 (Stata, College Station, TX). A P-value of <0.05 was considered to be significant.
Results
A total of 458 infants with a BW<1350 g were admitted to the neonatal intensive care unit at Magee-Womens Hospital from July 1997 to February 1999. In all, 431 infants met eligibility criteria and are included in this study. In all, 70 infants (16.2%) had meconium identified on placental examination by a positive stain on H&E and no staining by Prussian blue. Demographic variables are shown in Table 1 . Infants that passed meconium in utero were younger, weighed less and were more likely to be delivered via Caesarian section than those without meconium. Gender and race did not differ between infants who passed meconium in utero and those that did not. The administration of antenatal steroids was similar between the two groups of infants. With the exception of chorioamnionitis, pregnancy complications did not differ between the groups. Chorioamnionitis was identified Infants were classified as small for gestational age (SGA) when their birth weight was below the fifth percentile for their age. Being classified as SGA was not associated with an increased risk of in utero meconium passage (P ¼ 0.53).
Infants who passed meconium in utero were more likely to receive all forms of resuscitation than were control infants ( Table 2) . They more often were intubated in the delivery room (62.9 vs 47.7%, P ¼ 0.02), received chest compressions (17.1 vs 6.4%, P ¼ 0.003), and were given early volume resuscitation (32.9 vs 15.5%, P ¼ 0.001). Additionally, 1 and 5 min Apgar scores were lower for infants who passed meconium in utero when compared to those without meconium (Apgar scores at 1 and 5 min: 5 and 8 vs 6 and 8, respectively, P<0.05).
Infants who passed meconium in utero were more likely to have grade III-IV intraventricular hemorrhages than were infants who did not pass meconium (Table 3; 13.2 vs 5.0%, P ¼ 0.011). The difference in grade III-IV intraventricular hemorrhage remained significant when binary logistic regression was performed using gestational age, birth weight, antenatal steroids, and chorioamnionitis as confounding factors (P ¼ 0.047, 0.032, 0.015 and 0.015, respectively). There was no difference between groups in the incidence of periventricular leukomalacia.
The incidence of bronchopulmonary dysplasia differed between the two groups. Bronchopulmonary dysplasia was diagnosed in 56.7% of infants that passed meconium, and in 41.5% of infants without meconium (P ¼ 0.022). However, the incidence of other adverse outcomes including respiratory distress syndrome, necrotizing enterocolitis and death did not differ between the infants that passed meconium in utero and those that did not (Table 3) .
Discussion
The passage of meconium in utero is common among term and post-term infants in whom it is a marker of the infant at risk for adverse outcomes. Our study using routine pathologic staining of the fetal membranes as the criterion for meconium presence would indicate that the in utero passage of meconium by premature infants is more common than previously reported and is associated with adverse neonatal outcomes.
The previously reported incidence of meconium passage in utero among premature infants is 3-6.7%. 1, [3] [4] [5] [6] The incidence in our study is 16.2%. Thus when describing the incidence of All values are n (%), unless otherwise noted. Table 3 Adverse outcomes
Grade III-IV IVH a 9 (13) 18 (5) meconium passage by premature infants, a clear distinction should be made as to whether the meconium is present grossly (the placenta is green) or whether it is only seen by microscopic techniques. This study group by nature does not have a normal control group as pregnancies are not interrupted at this age group naturally. Thus to determine if these microscopic quantities of meconium are normal for gestational age or reflective of intrauterine stress would require examination of rare cases of accidental maternal death as an example. One possible explanation for the under-reporting of meconium passage in preterm infants is the bias to ignore small quantities of pigment on routine examination. This may be related to the lack of appreciation that these small amounts of pigment represent meconium or that they have a significance, worthy of reporting. We suspect that the meconium is passed by premature infants at a greater frequency than reported previously, but that the quantity of meconium passed by preterm infants is not easily visible except under higher-powered magnification. Additionally, in many clinical settings, it may not be practical to do the specialized studies that distinguish different pigment types. Meconium can be confused with hemosiderin and possibly acid hematin. The Prussian blue iron stain reliably distinguishes hemosiderin from meconium, and picric acid solubility reliably distinguishes acid hematin. Using these stains, the presence of meconium can be inferred by the absence of hemosiderin and acid hematin.
A second explanation for the reportedly low incidence of meconium passage by the premature fetus may relate to the relative quantities of meconium and amniotic fluid. Amniotic fluid volume increases until 32-35 weeks gestation and then decreases. 17 Full-term and post-term infants who pass meconium pass relatively large quantities into a small volume of amniotic fluid. The premature fetus will pass a smaller quantity of meconium, which is then diluted in the larger amniotic fluid volume. Such small quantities of meconium, although not visible in the amniotic fluid, may none-the-less represent the same degree of hypoxia as does visible meconium in the term infant.
Meconium staining of the amniotic fluid has been one of the classic signs of fetal distress in utero. The etiology of the passing of meconium is unclear. Three theories exist on the passage of meconium. One proposes that meconium passes as a response to fetal hypoxia; 18 while the second states that it may represent normal physiologic maturation of the fetal gastrointestinal tract. 19, 20 The third theory states that meconium passage may occur because of 'vagal stimulation from transient umbilical cord entrapment and the resultant increased peristalsis.' 21 Whether meconium passage in preterm infants occurs as a physiologic process or as the result of a hypoxemic event, there is little doubt that the in utero passage of large volumes of meconium is an indicator of risk for adverse outcomes.
Our results indicate that very low birth weight infants who passed microscopically-detectable quantities of meconium in utero were more likely to receive all forms of resuscitation and to more frequently experience grades III-IV intraventricular hemorrhage than were infants who did not pass meconium. The difference in grades III-IV intraventricular hemorrhage remained significant when binary logistic regression was performed using the major risk factors for intraventricular hemorrhages (younger gestational age, lower birth weight, lack of antenatal steroids, and chorioamnionitis) as confounding factors. Critical predisposing events leading to intraventricular hemorrhages are thought to be fluctuations of arterial blood pressure 22 and cerebral blood flow 23 leading to an ischemia reperfusion injury to the capillaries in the germinal matrix. Thus, we hypothesize that the presence of meconium on placentas of premature newborns is an indicator of fetal hypoxia, may be associated with cerebral hypoperfusion, subsequent ischemic reperfusion injury and potentially severe intraventricular hemorrhages.
In summary, we have demonstrated that a large percentage of VLBW infants appear to have to have microscopic quantities of meconium in their fetal membranes, a previously underreported finding, the significance of which is not certain. The use of more sensitive microscopic techniques may allow for the detection of small quantities of meconium, not visible by the human eye, and thus potentially aid in identifying infants at increased risk for adverse outcomes.
